120 related articles for article (PubMed ID: 660467)
21. Propranolol in pregnancy three year prospective study.
Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ
Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid chromatography.
Schaefer HG; Spahn H; Lopez LM; Derendorf H
J Chromatogr; 1990 May; 527(2):351-9. PubMed ID: 2387882
[TBL] [Abstract][Full Text] [Related]
23. Determination of propranolol and its major metabolite, naphthoxylactic acid, in human plasma by high performance liquid chromatography.
Takei H; Ogata H; Ejima A
Chem Pharm Bull (Tokyo); 1983 Apr; 31(4):1392-4. PubMed ID: 6627514
[No Abstract] [Full Text] [Related]
24. Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow-release propranolol administration.
Drummer OH; McNeil J; Pritchard E; Louis WJ
J Pharm Sci; 1981 Sep; 70(9):1030-2. PubMed ID: 6101148
[TBL] [Abstract][Full Text] [Related]
25. High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasma.
Miller RB
J Pharm Biomed Anal; 1991; 9(10-12):953-8. PubMed ID: 1822218
[TBL] [Abstract][Full Text] [Related]
26. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
Nation RL; Peng GW; Chiou WL
J Chromatogr; 1978 May; 145(3):429-36. PubMed ID: 659528
[TBL] [Abstract][Full Text] [Related]
27. Massive propranolol metabolite retention during maintenance hemodialysis.
Stone WJ; Walle T
Clin Pharmacol Ther; 1980 Oct; 28(4):449-55. PubMed ID: 7408404
[TBL] [Abstract][Full Text] [Related]
28. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
[TBL] [Abstract][Full Text] [Related]
29. Quantitative TLC determination of propranolol in human plasma.
Hadzija BW; Mattocks AM
J Pharm Sci; 1978 Sep; 67(9):1307-9. PubMed ID: 690840
[TBL] [Abstract][Full Text] [Related]
30. Determination of propranolol enantiomers in plasma and urine by spectrofluorimetry and second-order standard addition method.
Valderrama P; Poppi RJ
Anal Chim Acta; 2009 Sep; 651(1):31-5. PubMed ID: 19733731
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry.
Partani P; Modhave Y; Gurule S; Khuroo A; Monif T
J Pharm Biomed Anal; 2009 Dec; 50(5):966-76. PubMed ID: 19640669
[TBL] [Abstract][Full Text] [Related]
32. Simplified high-performance liquid chromatographic method for propranolol and five metabolites in liver perfusate, rat serum and dog plasma.
Semple HA; Xia F
J Chromatogr B Biomed Appl; 1994 May; 655(2):293-9. PubMed ID: 8081477
[TBL] [Abstract][Full Text] [Related]
33. Determination of propranolol and its major metabolites in plasma and urine by high-performance liquid chromatography without solvent extraction.
Lo M; Riegelman S
J Chromatogr; 1980 Aug; 183(2):213-20. PubMed ID: 7400279
[TBL] [Abstract][Full Text] [Related]
34. Quantitative account of propranolol metabolism in urine of normal man.
Walle T; Walle UK; Olanoff LS
Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
[TBL] [Abstract][Full Text] [Related]
35. Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography.
Pritchard JF; Schneck DW; Hayes AH
J Chromatogr; 1979 Jan; 162(1):47-58. PubMed ID: 762208
[TBL] [Abstract][Full Text] [Related]
36. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
37. The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions.
Vu VT; Abramson FP
Drug Metab Dispos; 1980; 8(5):300-4. PubMed ID: 6107225
[TBL] [Abstract][Full Text] [Related]
38. A sensitive fluorescence optosensor for analysing propranolol in pharmaceutical preparations and a test for its control in urine in sport.
Fernández-Sánchez JF; Carretero AS; Cruces-Blanco C; Fernández-Gutiérrez A
J Pharm Biomed Anal; 2003 Apr; 31(5):859-65. PubMed ID: 12684098
[TBL] [Abstract][Full Text] [Related]
39. Effect of dose and uremia on plasma and urine profiles of propranolol metabolites.
Schneck DW; Pritchard JF; Gibson TP; Vary JE; Hayes AH
Clin Pharmacol Ther; 1980 Jun; 27(6):744-55. PubMed ID: 7379441
[TBL] [Abstract][Full Text] [Related]
40. Immunoaffinity isolation of the sulfate conjugate of 4'-hydroxypropranolol from plasma.
Eller TD; Walle UK; Walle T
J Chromatogr; 1993 Feb; 612(2):320-5. PubMed ID: 8468392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
